Drawing for Serial No. 87707514

USPTO serial 87707514

Serial No. 87707514

Reviewed by CopyMark Law Group

Reg. 6301669Status 701Renewal
Filing date
Status date
Registration date
Mar 23, 2021
Examiner
FOSDICK, GEOFFREY A
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with Serial No. 87707514?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Devices worn to relieve pain and promote healing of spinal stenosis, namely, orthopedic beltsACTIVEJan 1, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 27, 2026NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jun 27, 20268.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jun 27, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 23, 2026ES8RTEAS SECTION 8 RECEIVED—
Mar 23, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 23, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 16, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 15, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 11, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 7, 2021IUAFUSE AMENDMENT FILED—
Feb 7, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 21, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2020EX5GSOU EXTENSION 5 GRANTED—
Nov 15, 2020EXT5SOU EXTENSION 5 FILED—
Nov 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 16, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 15, 2020EX4GSOU EXTENSION 4 GRANTED—
Jun 15, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 2, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Jun 2, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jun 2, 2020PETGPETITION TO REVIVE-GRANTED—
Jun 2, 2020PROATEAS PETITION TO REVIVE RECEIVED—
May 15, 2020EXT4SOU EXTENSION 4 FILED—
Nov 19, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 15, 2019EX3GSOU EXTENSION 3 GRANTED—
Nov 15, 2019EXT3SOU EXTENSION 3 FILED—
Nov 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2019EX2GSOU EXTENSION 2 GRANTED—
May 15, 2019EXT2SOU EXTENSION 2 FILED—
May 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 17, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 15, 2018EX1GSOU EXTENSION 1 GRANTED—
Nov 15, 2018EXT1SOU EXTENSION 1 FILED—
Nov 15, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 8, 2018ALIEASSIGNED TO LIE—
Jan 23, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 23, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jan 23, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 23, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 23, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 22, 2018DOCKASSIGNED TO EXAMINER—
Dec 15, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 14, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 7, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance